Monitor for actual sales by the selling stockholders, particularly Armistice Capital and Intracoastal Capital, as their selling activity could significantly pressure the stock price. The lack of proceeds to the company combined with the large number of shares registered suggests this is a liquidity event for investors rather than a capital raise for the company.
Price Chart
Executive Summary
Enveric Biosciences has filed an S-3 shelf registration to register 6,822,225 shares of common stock for resale by selling stockholders, including shares issued in a recent private placement and shares underlying pre-funded and common warrants. The company will not receive any proceeds from the sales, which could lead to significant dilution and downward pressure on the stock price given the company's $7M market cap.
Key Financial Metrics
Key Facts
- 6,822,225 shares registered for resale by selling stockholders, including Armistice Capital (5M shares), Intracoastal Capital (999,999 shares), and others
- Company will not receive any proceeds from the resale of these shares
- Shares being registered include 98,000 common shares, 2,124,223 from pre-funded warrants, 4,444,446 from common warrants, and 155,556 from placement agent warrants
- Market cap is approximately $7M, making the registered shares represent a significant potential dilution
- Stock price has been volatile, ranging from $1.79 to $17.40 over the past year
Financial Impact
The registered shares represent approximately 78% of the current market cap at $1.84 per share, creating substantial dilution risk
Risk Factors
- Significant downward pressure on stock price from potential large-scale selling
- Dilution of existing shareholders if warrants are exercised
- Company's ability to continue as a going concern given its financial needs
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001493152-26-018724 |
| Exhibit: ex107.htm | 0001493152-26-018724 |
| Exhibit: ex5-1.htm | 0001493152-26-018724 |
| Exhibit: ex23-2.htm | 0001493152-26-018724 |
| Exhibit: ex23-1.htm | 0001493152-26-018724 |
| Document: 0001493152-26-018724-index-headers.html | 0001493152-26-018724 |
| Document: 0001493152-26-018724-index.html | 0001493152-26-018724 |
| Document: 0001493152-26-018724.txt | 0001493152-26-018724 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 8-K | $1.48 $1.46 | ▲ +1.35% | ▼ −0.63% | $1.38 (+6.76%) |
Jun 9, 2026 19w ago | 8-K | $1.62 $1.43 | ▲ +11.73% | ▲ +15.35% | $1.38 (+14.81%) |
Jun 9, 2026 19w ago | 424B5 | $1.62 $1.43 | ▲ +11.73% | ▲ +15.35% | $1.38 (+14.81%) |
May 29, 2026 21w ago | 8-K | $2.26 $1.38 | ▲ +38.94% | ▲ +37.64% | $1.38 (+38.94%) |
May 15, 2026 23w ago | 8-K | $2.25 $1.48 | ▼ −34.22% | ▼ −36.34% | $1.38 (−38.67%) |
Apr 23, 2026 26w ago | S-3 | $5.04 $2.22 | ▲ +55.95% | ▲ +59.98% | $1.38 (+72.62%) |
Apr 14, 2026 27w ago | DEFA14A | $2.03 $2.52 | ▲ +24.14% | ▲ +18.09% | $1.38 (−32.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers